My research focuses on detecting and degrading major contaminants, specifically PFAS. I am working on developing analytical approaches for PFAS detection in water, human blood, and fish using tools like LC-MS/MS, LC-IMS/QToF, ICP-MS, etc.
My research is focused on the synthesis of doped-quantum dot/MxV2O5 heterostructures and characterization of their photoinduced interfacial charge-transfer dynamics for applications in photocatalytic CO2 reduction and hydrogen generation.
My research focuses on using density functional theory and crystal structure prediction to explore new materials, as well as establish surface chemistry behavior.
My research focuses on the design, synthesis, and analysis of paramagnetic Co(II)-based chemical exchange saturation transfer (paraCEST) agents as potential MRI probes, with an overall goal of enhancing the paraCEST sensitivity for pre-clinical translation of this technique.
My work centers on challenging ene-yne and olefin cross metatheses catalyzed by ruthenium carbene catalysts. These highly functionalized dienyl/olefinic cross products were also used in a variety of functionalization reactions to expand their synthetic utility.
My research involves understanding the partition of perfluoroalkyl substances (PFAS) in sorbents used for separation and studying PFAS distribution in heterogeneous environmental and biological samples. To achieve these goals, I use micro separation methodologies for preconcentration which is hyphenated to liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify and identify PFAS.
My research is centered around developing stable solid electrolyte interphase (SEI) layers for NaK alloy batteries. To achieve this, we use in situ characterization techniques to determine the composition of the SEI layer. Additionally, I am involved in studying the electro-Fenton process for generating hydroxyl radicals which can help degrade Perfluoroalkyl substances in water.
My research focuses on understanding the molecular factors that enhance a compounds activity against a protein in drug discovery and development. Specifically, I develop and study inhibitors of NADPH Oxidases and Epidermal growth factor receptor, to understand the structural features that enable the development of potent inhibitors against these enzymes for the treatment of several diseases.
